Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen Plans R&D Center in China
GenEngNews
Fri, 09/27/13 - 08:32 am
Tags:
Amgen, R&D, China
Ex-CEO of Amgen, Kevin Sharer, on Leadership
Harvard Business Review
Thu, 09/26/13 - 08:21 am
Tags:
Amgen, Leadership, Pharma CEOs, Kevin Sharer
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Tags:
Biogen Idec, AbbVie, Amgen, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Cephalon
Acceleron: A Small Biotech Preparing To Supply Big Markets
Seeking Alpha
Mon, 09/23/13 - 09:47 am
Tags:
Acceleron, Amgen, Celgene, IPOs
With $29B in deals so far, 2013 shaping up as big M&A year
Fierce Pharma
Fri, 09/20/13 - 10:23 am
Tags:
M&A, Valeant Pharmaceuticals, Bausch & Lomb, ONYX Pharmaceuticals, Amgen
[video]Biotech IPOs With Big Partners
TheStreet.com
Thu, 09/19/13 - 03:13 am
Tags:
biotech, IPOs, Celgene, Amgen, Bind Therapeutics, Acceleron, Fate Therapeutics
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis, Humira, AbbVie, Enbrel, Amgen, Remicade, Janssen, Celebrex, Pfizer, Bristol-Myers Squibb, Orencia, Cimza, UCB, Simponi, JNJ, Arthrotec, Vimovo, AstraZeneca, Kineret
Fallout From This Heart-Drug Failure
Motley Fool
Sat, 09/14/13 - 10:49 am
Tags:
Amgen, Omecamtiv Mecarbil, heart failure, Cytokinetics
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Tags:
Amgen, Celgene, ONYX Pharmaceuticals, Keryx, Pluristem Therapeutics, NPS Pharmaceuticals
Can This Biotech Star Deliver for Dividend Investors?
Motley Fool
Sat, 09/14/13 - 10:35 am
Tags:
Amgen
Cheers and Jeers for Amgen's Pipeline
Motley Fool
Thu, 09/12/13 - 08:13 am
Tags:
Amgen, AMG-145, Omecamtiv Mecarbil
This Week in Biotech
Motley Fool
Sun, 09/8/13 - 11:09 am
Tags:
Astex, Otsuka, Rockwell Medical, Theravance, GSK, Cytokinetics, Amgen
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 09/7/13 - 11:48 am
Tags:
MiMedx, Cytokinetics, Amgen, Vivus
Onyx Sued by Investors Claiming Amgen Buyout Is Too Cheap
Bloomberg
Sat, 09/7/13 - 11:44 am
Tags:
ONYX Pharmaceutical, Amgen, M&A, lawsuits
Amgen With Onyx Pharmaceuticals: Long-Term Analysis
Seeking Alpha
Wed, 09/4/13 - 01:15 pm
Tags:
Amgen, ONYX Pharmaceuticals, M&A
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Fierce Biotech
Tue, 09/3/13 - 11:19 am
Tags:
Coherus Biosciences, Baxter International, Enbrel, biosimilars, Amgen
Amgen, Cytokinetics Report Mixed Results For Heart Failure Drug
TheStreet.com
Tue, 09/3/13 - 10:39 am
Tags:
Amgen, Cytokinetics, heart failure, Omecamtiv Mecarbil
Will Amgen's Purchase Of Onyx Prove To Be A Smart Move?
Seeking Alpha
Fri, 08/30/13 - 10:02 am
Tags:
Amgen, M&A, ONYX Pharmaceuticals
Onyx spells out layoff policies as staffers brace for post-buyout cuts
Fierce Biotech
Thu, 08/29/13 - 11:14 am
Tags:
layoffs, Amgen, ONYX Pharmaceuticals, M&A
Pharma Deal Volumes Rise as Early-Stage Drugs Draw Interest
WSJ Online
Thu, 08/29/13 - 09:43 am
Tags:
M&A, ONYX Pharmaceuticals, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.